The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors.
about
Identification of microRNAs as potential prognostic markers in ependymomaTelomere maintenance and dysfunction predict recurrence in paediatric ependymomaPrognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomasMicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System TumoursCerebellopontine angle ependymoma in a 2-year- old child.Use of T2 signal intensity of cerebellar neoplasms in pediatric patients to guide preoperative staging of the neuraxis.Maximum likelihood estimation of reviewers' acumen in central review setting: categorical data.Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomasHistopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts.Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified.Infratentorial ependymomas--a study of the centre in KatowiceAltered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsDistinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.Supratentorial ependymoma: disease control, complications, and functional outcomes after irradiationPediatric neurosurgery-science, art, and humility: reflection of personal experience.Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymomaPediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesThe current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.Ependymomas: development of immunotherapeutic strategies.Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomasFinal results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.p16 Loss and E2F/cell cycle deregulation in infant posterior fossa ependymoma.Impact of radiation therapy and extent of resection for ependymoma in young children: A population-based study.Identification of microRNA signature in different pediatric brain tumors.Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas
P2860
Q21135016-193B3CEA-1D2A-487C-B7CB-462EC12A3594Q24652958-886F0024-F9BC-42F2-893F-A556EB21A941Q24656634-4C9CBDC1-0C09-4755-8A15-3E576C951DF8Q27002604-61237FAC-62BF-4A27-8DC8-08846E7BC25FQ30464973-C822869E-7D4A-4856-ACE3-246963DA32F5Q33809749-E60DAF34-2059-4249-A8AB-7E5D153B3C32Q33856450-A73647DC-E496-4D86-99F9-1020A68D2424Q34285237-8C357C3A-AB24-4425-8BC9-993BA663AF8BQ34992547-18155134-3561-420E-A81B-392103BB4050Q35053098-1D4E6BEC-0EF5-4F1C-B392-7702E974E264Q35815310-091E94FE-64FE-4951-92D5-0503DDDCBCB4Q35825515-82BC3CB4-ABE2-4E60-B63B-825748ECBAABQ36070798-43168F99-6752-4417-B9FE-924D89BF8A3EQ36461766-F3F70F6D-B58A-4F45-803F-357D20CDA8E9Q36560149-C4644F0C-FBCB-465F-A5F7-6F5BE3DFE4FDQ36994639-B2F0DA81-7876-4E84-9CE4-8E0E352A7FEDQ37154646-4B4BE357-265D-418C-9AE2-5F5B24AEAB95Q37196135-E369E60E-D314-47FC-B6D5-3DA618CC3C92Q37213305-8300F935-59C0-4384-9B62-9CA95125E283Q37553466-FFDF57F8-0FC0-467F-85C0-128FF03DBFD3Q37641698-8CC9F8A1-4CFD-4A90-9EB0-8EF649323AB3Q37678294-38BEDBDA-D0DE-4D84-8683-8195ACEF7582Q38003799-0C0B0DDF-F827-4EA3-A1EE-2FFEC6B56A41Q38865516-8EFF7127-FBE4-4412-A578-31AF416CC4B6Q39451532-662C416D-7C24-4843-AFD4-AF92BDE829FFQ47107760-F614F6E4-07A1-4134-BFA0-2BC900765645Q47852181-243E63A3-BA4B-4E95-B5CD-A923013581E0Q55174213-EAA3B946-CFA5-4DED-B931-A9948B7269C8Q57652291-5D34AA8A-76CF-44D3-990A-5733367544D7
P2860
The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The prognostic value of histol ...... review of prognostic factors.
@ast
The prognostic value of histol ...... review of prognostic factors.
@en
The prognostic value of histol ...... review of prognostic factors.
@nl
type
label
The prognostic value of histol ...... review of prognostic factors.
@ast
The prognostic value of histol ...... review of prognostic factors.
@en
The prognostic value of histol ...... review of prognostic factors.
@nl
prefLabel
The prognostic value of histol ...... review of prognostic factors.
@ast
The prognostic value of histol ...... review of prognostic factors.
@en
The prognostic value of histol ...... review of prognostic factors.
@nl
P2093
P2860
P1433
P1476
The prognostic value of histol ...... review of prognostic factors.
@en
P2093
Elisabeth J Rushing
Emi Holmes
Peter C Burger
Sema Ozuysal
Tarik Tihan
Tianni Zhou
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800999
P577
2007-12-14T00:00:00Z
P5875
P6179
1031794503